Eargo announces strategic additions to board of directors following patient square capital becoming new majority shareholder

San jose, calif., dec. 07, 2022 (globe newswire) -- eargo, inc. (“eargo” or the “company”) (nasdaq: ear), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the appointments of several new directors following the closing of the company's rights offering as previously announced on november 29, 2022. patient square capital became the company's majority owner upon closing of the rights offering and conversion of patient square's senior secured convertible notes per its investment in june 2022.
EAR Ratings Summary
EAR Quant Ranking